Quick Answer
FATE THERAPEUTICS INC reported Revenue (ASC 606) of $6.65 million for fiscal year 2025.
FATE THERAPEUTICS INC Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $6.65M | -51.2% |
| 2024 | $13.63M | -78.5% |
| 2023 | $63.53M | -34.0% |
| 2022 | $96.30M | +72.4% |
| 2021 | $55.85M | +77.7% |
| 2020 | $31.43M | +194.3% |
| 2019 | $10.68M | +125.3% |
| 2018 | $4.74M | +15.4% |
| 2017 | $4.11M | -6.7% |
| 2016 | $4.40M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.74M | -43.4% | -8.7% |
| June 30, 2025 | $1.91M | -71.8% | +17.1% |
| March 31, 2025 | $1.63M | -15.4% | -47.0% |
| September 30, 2024 | $3.07M | +58.1% | -54.6% |
| June 30, 2024 | $6.77M | +625.8% | +251.8% |
| March 31, 2024 | $1.93M | -96.7% | -1.0% |
| September 30, 2023 | $1.94M | -87.0% | +108.4% |
| June 30, 2023 | $933.0K | -95.0% | -98.4% |
- FATE THERAPEUTICS INC showed a decrease of -51.2% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2016–2025 period, FATE THERAPEUTICS INC’s revenue (asc 606) has grown by 51.0% (from $4.40 million to $6.65 million).
- The most recent figure is from FATE THERAPEUTICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: